» Authors » Suntje Sander-Struckmeier

Suntje Sander-Struckmeier

Explore the profile of Suntje Sander-Struckmeier including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 11
Citations 164
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Noureddin M, Sander-Struckmeier S, Mato J
World J Hepatol . 2020 Mar; 12(2):46-63. PMID: 32184941
Background: S-adenosylmethionine (AdoMet) is a metabolically pleiotropic molecule used to treat intrahepatic cholestasis (IHC) and chronic liver diseases. While the efficacy of AdoMet has been demonstrated previously, it has not...
2.
Ivashkin V, Maevskaya M, Kobalava Z, Uspenskiy Y, Fominih J, Rozanov A, et al.
Minerva Gastroenterol Dietol . 2018 Feb; 64(3):208-219. PMID: 29431335
Background: The effect of oral and/or parenteral ademetionine (500 mg intravenous [IV] and tablet formulation) on clinical symptoms and biochemical markers of intrahepatic cholestasis (IHC) was investigated in subjects with...
3.
Whitcomb D, Bodhani A, Beckmann K, Sander-Struckmeier S, Liu S, Fuldeore M, et al.
Pancreas . 2015 Oct; 45(5):679-86. PMID: 26495784
Objectives: The aim of this study was to perform exploratory analyses of the efficacy and safety of pancrelipase delayed-release capsules (Creon) in patients with exocrine pancreatic insufficiency (EPI) with (n...
4.
Kashirskaya N, Kapranov N, Sander-Struckmeier S, Kovalev V
J Cyst Fibros . 2014 Jul; 14(2):275-81. PMID: 25066363
Background: Pancreatic enzyme replacement therapy is the foundation of nutritional management for exocrine pancreatic insufficiency (EPI). Methods: A 3-month, open-label, multicentre study in Russia assessing safety, efficacy, and ease-of-use of...
5.
Kahl S, Schutte K, Glasbrenner B, Mayerle J, Simon P, Henniges F, et al.
JOP . 2014 Mar; 15(2):165-74. PMID: 24618443
Context: Pancreatic exocrine insufficiency is a significant problem after acute pancreatitis. Objective: To evaluate whether oral pancreatic enzyme supplementation improves the recovery of pancreatic exocrine function and to explore the...
6.
Sander-Struckmeier S, Beckmann K, Janssen-van Solingen G, Pollack P
Pancreas . 2013 Apr; 42(6):983-9. PMID: 23587850
Objectives: This study aimed to determine whether the efficacy of pancrelipase/pancreatin (CREON®) may be affected by the concomitant use of proton pump inhibitors (PPIs)/histamine-2 receptor antagonists (H2RAs). Methods: An analysis...
7.
Caras S, Boyd D, Zipfel L, Sander-Struckmeier S
J Pediatr Gastroenterol Nutr . 2011 Jun; 53(6):634-40. PMID: 21681115
Objective: The standard measure of pancreatic enzyme replacement therapy (PERT) efficacy in treating exocrine pancreatic insufficiency (EPI) is the coefficient of fat absorption (CFA). CFA measurement involves 72-hour stool collection,...
8.
Littlewood J, Connett G, Sander-Struckmeier S, Henniges F
Expert Opin Drug Saf . 2011 Feb; 10(2):197-203. PMID: 21342076
Objective: At the request of the Medicines and Healthcare Regulatory Agency and in agreement with the appropriate authorities, an observational, multi-center, non-interventional, post-authorization safety study of high-strength pancreatic enzymes was...
9.
Whitcomb D, Lehman G, Vasileva G, Malecka-Panas E, Gubergrits N, Shen Y, et al.
Am J Gastroenterol . 2010 May; 105(10):2276-86. PMID: 20502447
Objectives: Pancreatic-enzyme replacement therapy (PERT) is the standard of care to prevent maldigestion, malnutrition, and excessive weight loss in patients with exocrine pancreatic insufficiency (EPI) due to chronic pancreatitis (CP)...
10.
Carriere F, Grandval P, Gregory P, Renou C, Henniges F, Sander-Struckmeier S, et al.
JOP . 2005 May; 6(3):206-15. PMID: 15883471
Thirty years ago, it was reported that a linear relationship does not exist between the amounts of human pancreatic lipase secreted in chronic pancreatitis and the degree of steatorrhea, which...